טוען...
Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
For well over 30 years, the botulinum neurotoxin (BoNT) has been used for a large number of indications, some of which however have not been licensed. Admittedly, approval varies in many countries and this permits a large spectrum for evaluation. Thus, BoNT is used for patients with Parkinson’s dise...
שמור ב:
| הוצא לאור ב: | Toxins (Basel) |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7910947/ https://ncbi.nlm.nih.gov/pubmed/33503872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins13020087 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|